A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

DOMINICK REUTER/AFP/AFP Europe's medicines watchdog on Thursday partially approved a marketing request for a ... or mild ...

specifically in comparing approval regulatory cycles for the Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Last year we wrote a three-part series, "Life in the Fast ...

Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...

It's not known whether the company will submit a separate application for approval to the UK regulator, the MHRA. The European Medicines Agency based its decision on two main studies of more than ...

The CHMP recommended approval granting marketing authorization ... with generally low-grade symptomatic adverse events. The European Commission (EC) will decide in approximately two months.

The European Medicines Agency has recommend olaparib for approval for women with ovarian cancer who have a BRCA mutation - the first time a cancer drug will have been approved targeted at an inherited ...

One of Royal Mail’s Christmas stamps may ring some bells for some people in Northern Ireland. This year’s festive collection features illustrations of five cathedrals, including St Patrick’s ...

In the Autumn Budget, stamp duty for buy-to-let properties and second homes increased by two percentage points. The table shows the current buy-to-let stamp duty rates in England and Northern Ireland.

announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Kisqali (ribociclib). The CHMP recommended approval ...